AHA 2023 Insights

 

 
 

 

AHA 2023 Insights: Safety and Efficacy of DOAC vs Warfarin in Obese Patients with Atrial Fibrillation - A Systematic Review and Meta-Analysis

498 views
January 12, 2024
Comments 1
Login to view comments. Click here to Login